ICUI, US44930G1076

MarketBeat rates ICU Medical stock Moderate Buy with USD 200 target

Published on 10/07/2026 at 06:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nine analysts set an average target of USD 192.80. For ICU Medical stock, revenue reached USD 551.70 million in the second quarter of 2026.

ICUI, US44930G1076, Illustration mit AI erstellt.
ICUI, US44930G1076, Illustration mit AI erstellt.

ICU Medical, Inc. (ISIN US44930G1076) has a Moderate Buy consensus, with a USD 200.00 target from Raymond James among the latest analyst views. MarketBeat reported on October 5, 2026 that nine analysts rated the stock Moderate Buy, including four buys, two strong buys and three holds, with an average 12-month target of USD 192.80.

Targets reach USD 200

The analyst range includes Piper Sandler at USD 195.00, Needham at USD 187.00 and KeyCorp at USD 182.00. Raymond James set a USD 200.00 target, while Sanford C. Bernstein downgraded ICU Medical to Market Perform in a report dated June 15, 2026, according to MarketBeat.

Second-quarter revenue holds steady

Simply Wall St reported that ICU Medical generated USD 551.70 million in revenue in the second quarter of 2026, flat against USD 548.87 million in the second quarter of 2025. Diluted earnings per share came to USD 0.76, down from USD 1.43, while net income was USD 19.10 million, down 46.00 percent year over year.

The company also updated fiscal 2026 guidance in August, according to its investor-relations page. The combination of steady reported revenue and lower quarterly earnings leaves margin execution as the key counterweight to the higher analyst targets.

Nasdaq quote stays below yearly high

ICUI was last at USD 159.73 on the Nasdaq on October 6, 2026 at 4:00 p.m. ET in after-hours trading, down 1.03 percent from the USD 161.40 prior close. The 52-week range was USD 112.50 to USD 192.85 on October 5, 2026, placing the last quote USD 33.12 below the high, or 17.17 percent.

Lang & Schwarz shows a prior close of EUR 141.50 for October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of ICU Medical stock.

ICU Medical stock facts

  • Company: ICU Medical, Inc.
  • ISIN: US44930G1076
  • Ticker: ICUI
  • Primary exchange: Nasdaq
  • Prior close Lang & Schwarz (October 5, 2026): EUR 141.50
  • Market capitalization: USD 4.0 billion (as of October 6, 2026)
  • 52-week range: USD 112.50-192.85 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

More news and analyses on ICU Medical stock

Disclaimer...

en | US44930G1076 | ICUI | boerse | 70250381 | bgmi